Review



non targeting control sequence  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Addgene inc non targeting control sequence
    Non Targeting Control Sequence, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 33 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/non targeting control sequence/product/Addgene inc
    Average 94 stars, based on 33 article reviews
    non targeting control sequence - by Bioz Stars, 2026-03
    94/100 stars

    Images



    Similar Products

    94
    Addgene inc non targeting control sequence
    Non Targeting Control Sequence, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/non targeting control sequence/product/Addgene inc
    Average 94 stars, based on 1 article reviews
    non targeting control sequence - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    90
    Shanghai GenePharma shrna sequences targeting mettl16 and pparγ, and non-targeting negative control (sh-nc)
    Shrna Sequences Targeting Mettl16 And Pparγ, And Non Targeting Negative Control (Sh Nc), supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/shrna sequences targeting mettl16 and pparγ, and non-targeting negative control (sh-nc)/product/Shanghai GenePharma
    Average 90 stars, based on 1 article reviews
    shrna sequences targeting mettl16 and pparγ, and non-targeting negative control (sh-nc) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology non targeting control shrna sequences
    Non Targeting Control Shrna Sequences, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/non targeting control shrna sequences/product/Santa Cruz Biotechnology
    Average 94 stars, based on 1 article reviews
    non targeting control shrna sequences - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    90
    Shanghai GenePharma non-targeting sequence (negative control, nc) (git2 (+)-nc
    Non Targeting Sequence (Negative Control, Nc) (Git2 (+) Nc, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/non-targeting sequence (negative control, nc) (git2 (+)-nc/product/Shanghai GenePharma
    Average 90 stars, based on 1 article reviews
    non-targeting sequence (negative control, nc) (git2 (+)-nc - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    94
    Addgene inc eleven target grna sequences
    Eleven Target Grna Sequences, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/eleven target grna sequences/product/Addgene inc
    Average 94 stars, based on 1 article reviews
    eleven target grna sequences - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    Addgene inc control grna sequence
    Control Grna Sequence, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/control grna sequence/product/Addgene inc
    Average 94 stars, based on 1 article reviews
    control grna sequence - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    90
    Shanghai Genechem Ltd lentiviral plasmid containing non-target control sequence (shnc)
    Lentiviral Plasmid Containing Non Target Control Sequence (Shnc), supplied by Shanghai Genechem Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lentiviral plasmid containing non-target control sequence (shnc)/product/Shanghai Genechem Ltd
    Average 90 stars, based on 1 article reviews
    lentiviral plasmid containing non-target control sequence (shnc) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher sirna sequences used here were: control non-targeting sirna, 5′-uagcgacuaaacacaucaa-3′
    Sirna Sequences Used Here Were: Control Non Targeting Sirna, 5′ Uagcgacuaaacacaucaa 3′, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sirna sequences used here were: control non-targeting sirna, 5′-uagcgacuaaacacaucaa-3′/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    sirna sequences used here were: control non-targeting sirna, 5′-uagcgacuaaacacaucaa-3′ - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    94
    Addgene inc grna target sequences
    (A) Strategy to generate CENP-C WT or CENP-C ∆M12BD RPE1 cells expressing mScarlet-CENP-A and GFP-H2A (see also ). (B) Schematic representation of mScarlet-CENP-A cDNA targeting into the endogenous CENP-A locus. To express mScarlet-fused CENP-A under the control of the endogenous CENP-A promoter, mScarlet-CENP-A cDNA was targeted into exon 1 by CRISPR/Cas9-mediated homologous recombination. Because the targeting constructs have puromycin resistance genes ( PuroR ) or neomycin resistance genes ( NeoR ), targeted cells were selected using these selection markers. The <t>gRNA</t> sequence and the position of primers for genotyping are shown. (C) Genotyping PCR and immunoblotting for mScarlet-CENP-A in mScarlet-CENP-A –introduced RPE-1 cells. Genotyping in isolated single clones was performed using the primers shown in (B). In immunoblots, CENP-A was detected by an antibody against CENP-A, and α-tubulin was probed as a loading control. (D) Schematic representation of GFP-H2A cDNA targeting into the AAVS1 locus ( PPP1R12C gene). To express GFP-fused histone H2A from the AAVS1 locus, GFP-H2A cDNA was targeted <t>into</t> <t>intron</t> 1 by CRISPR/Cas9-mediated homologous recombination. Because the targeting construct has blasticidin resistance genes ( BsR ), targeted cells were selected using the BsR marker. The gRNA sequence and the position of primers for genotyping are shown. (E) Genotyping PCR of GFP-H2A –introduced RPE-1 cells. Genotyping in an isolated single clone was performed using the primers shown in (D). (F) Schematic representation of FLAG-human CENP-C cDNA targeting into the endogenous human CENP-C locus. To express FLAG-tagged CENP-C wild-type (WT) or a Mis12C-binding domain deletion mutant (∆M12BD: ∆1-75) under the control of the endogenous CENP-C promoter, FLAG-CENP-C WT or ∆M12BD cDNA was targeted into exon 1 by CRISPR/Cas9-mediated homologous recombination. Because the targeting constructs have zeocin resistance genes ( ZeoR ) or histidinol resistance genes ( histidinol dehydrogenase : HisD ), targeted cells were selected using these selection markers. The gRNA sequence and the position of primers for genotyping are shown. (G) Genotyping PCR and immunoblotting for FLAG-CENP-C in FLAG-CENP-C –introduced RPE-1 cells. Genotyping in isolated single clones was performed using the primers shown in (F). In immunoblots, CENP-C was detected by an antibody against human CENP-C, and histone H3 was probed as a loading control. (H) Growth curve of CENP-C WT or CENP-C ∆M12BD RPE1 cells. The cell numbers were normalized to those at day 0 of each line. Error bars indicate the mean and SD. Two clones of CENP-C ∆M12BD RPE1 cells were examined.
    Grna Target Sequences, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/grna target sequences/product/Addgene inc
    Average 94 stars, based on 1 article reviews
    grna target sequences - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    Image Search Results


    (A) Strategy to generate CENP-C WT or CENP-C ∆M12BD RPE1 cells expressing mScarlet-CENP-A and GFP-H2A (see also ). (B) Schematic representation of mScarlet-CENP-A cDNA targeting into the endogenous CENP-A locus. To express mScarlet-fused CENP-A under the control of the endogenous CENP-A promoter, mScarlet-CENP-A cDNA was targeted into exon 1 by CRISPR/Cas9-mediated homologous recombination. Because the targeting constructs have puromycin resistance genes ( PuroR ) or neomycin resistance genes ( NeoR ), targeted cells were selected using these selection markers. The gRNA sequence and the position of primers for genotyping are shown. (C) Genotyping PCR and immunoblotting for mScarlet-CENP-A in mScarlet-CENP-A –introduced RPE-1 cells. Genotyping in isolated single clones was performed using the primers shown in (B). In immunoblots, CENP-A was detected by an antibody against CENP-A, and α-tubulin was probed as a loading control. (D) Schematic representation of GFP-H2A cDNA targeting into the AAVS1 locus ( PPP1R12C gene). To express GFP-fused histone H2A from the AAVS1 locus, GFP-H2A cDNA was targeted into intron 1 by CRISPR/Cas9-mediated homologous recombination. Because the targeting construct has blasticidin resistance genes ( BsR ), targeted cells were selected using the BsR marker. The gRNA sequence and the position of primers for genotyping are shown. (E) Genotyping PCR of GFP-H2A –introduced RPE-1 cells. Genotyping in an isolated single clone was performed using the primers shown in (D). (F) Schematic representation of FLAG-human CENP-C cDNA targeting into the endogenous human CENP-C locus. To express FLAG-tagged CENP-C wild-type (WT) or a Mis12C-binding domain deletion mutant (∆M12BD: ∆1-75) under the control of the endogenous CENP-C promoter, FLAG-CENP-C WT or ∆M12BD cDNA was targeted into exon 1 by CRISPR/Cas9-mediated homologous recombination. Because the targeting constructs have zeocin resistance genes ( ZeoR ) or histidinol resistance genes ( histidinol dehydrogenase : HisD ), targeted cells were selected using these selection markers. The gRNA sequence and the position of primers for genotyping are shown. (G) Genotyping PCR and immunoblotting for FLAG-CENP-C in FLAG-CENP-C –introduced RPE-1 cells. Genotyping in isolated single clones was performed using the primers shown in (F). In immunoblots, CENP-C was detected by an antibody against human CENP-C, and histone H3 was probed as a loading control. (H) Growth curve of CENP-C WT or CENP-C ∆M12BD RPE1 cells. The cell numbers were normalized to those at day 0 of each line. Error bars indicate the mean and SD. Two clones of CENP-C ∆M12BD RPE1 cells were examined.

    Journal: Life Science Alliance

    Article Title: CENP-C-Mis12 complex establishes a regulatory loop through Aurora B for chromosome segregation

    doi: 10.26508/lsa.202402927

    Figure Lengend Snippet: (A) Strategy to generate CENP-C WT or CENP-C ∆M12BD RPE1 cells expressing mScarlet-CENP-A and GFP-H2A (see also ). (B) Schematic representation of mScarlet-CENP-A cDNA targeting into the endogenous CENP-A locus. To express mScarlet-fused CENP-A under the control of the endogenous CENP-A promoter, mScarlet-CENP-A cDNA was targeted into exon 1 by CRISPR/Cas9-mediated homologous recombination. Because the targeting constructs have puromycin resistance genes ( PuroR ) or neomycin resistance genes ( NeoR ), targeted cells were selected using these selection markers. The gRNA sequence and the position of primers for genotyping are shown. (C) Genotyping PCR and immunoblotting for mScarlet-CENP-A in mScarlet-CENP-A –introduced RPE-1 cells. Genotyping in isolated single clones was performed using the primers shown in (B). In immunoblots, CENP-A was detected by an antibody against CENP-A, and α-tubulin was probed as a loading control. (D) Schematic representation of GFP-H2A cDNA targeting into the AAVS1 locus ( PPP1R12C gene). To express GFP-fused histone H2A from the AAVS1 locus, GFP-H2A cDNA was targeted into intron 1 by CRISPR/Cas9-mediated homologous recombination. Because the targeting construct has blasticidin resistance genes ( BsR ), targeted cells were selected using the BsR marker. The gRNA sequence and the position of primers for genotyping are shown. (E) Genotyping PCR of GFP-H2A –introduced RPE-1 cells. Genotyping in an isolated single clone was performed using the primers shown in (D). (F) Schematic representation of FLAG-human CENP-C cDNA targeting into the endogenous human CENP-C locus. To express FLAG-tagged CENP-C wild-type (WT) or a Mis12C-binding domain deletion mutant (∆M12BD: ∆1-75) under the control of the endogenous CENP-C promoter, FLAG-CENP-C WT or ∆M12BD cDNA was targeted into exon 1 by CRISPR/Cas9-mediated homologous recombination. Because the targeting constructs have zeocin resistance genes ( ZeoR ) or histidinol resistance genes ( histidinol dehydrogenase : HisD ), targeted cells were selected using these selection markers. The gRNA sequence and the position of primers for genotyping are shown. (G) Genotyping PCR and immunoblotting for FLAG-CENP-C in FLAG-CENP-C –introduced RPE-1 cells. Genotyping in isolated single clones was performed using the primers shown in (F). In immunoblots, CENP-C was detected by an antibody against human CENP-C, and histone H3 was probed as a loading control. (H) Growth curve of CENP-C WT or CENP-C ∆M12BD RPE1 cells. The cell numbers were normalized to those at day 0 of each line. Error bars indicate the mean and SD. Two clones of CENP-C ∆M12BD RPE1 cells were examined.

    Article Snippet: We amplified DNA fragments containing T7 promoter, gRNA target sequences (intron 1: CCAACACTATAGCTGACAAG; intron 4: AAACTGATAGAGTACAGTGG), and gRNA scaffold sequences by PCR using primers shown in Table S1 and pX330 (plasmid #42230; Addgene) ( ) as a template.

    Techniques: Expressing, Control, CRISPR, Homologous Recombination, Construct, Selection, Sequencing, Western Blot, Isolation, Clone Assay, Marker, Binding Assay, Mutagenesis

    (A) Strategy to generate CENP-T WT , CENP-T ∆NBD−1 , or CENP-T ∆NBD−2 RPE1 cells (see also ). In the cells, mini-auxin-inducible degron (mAID)–tagged human CENP-T was expressed together with OsTIR1 from the AAVS locus. Because mAID-fused CENP-T is degraded upon IAA (indole-3-acetic acid) treatment, mScarlet-tagged CENP-T is only expressed from the endogenous CENP-T locus in CENP-T WT , CENP-T ∆NBD−1 , or CENP-T ∆NBD−2 RPE1 cells. (B) Schematic representation of GFP-mAID-CENP-T and OsTIR1 cDNA targeting into the AAVS1 locus ( PPP1R12C gene). To express GFP- and mAID-fused human CENP-T and OsTIR1, the expression cassette was targeted into intron 1 by CRISPR/Cas9-mediated homologous recombination. Because the targeting construct has blasticidin resistance genes ( BsR ), targeted cells were selected using the BsR marker. The gRNA sequence and the position of primers for genotyping are shown. (C) Schematic representation of mScarlet-CENP-T cDNA targeting the endogenous CENP-T locus. To express mScarlet-tagged CENP-T WT or each of the Ndc80C-binding domain mutants (∆NBD-1: ∆6-31; ∆NBD-2: ∆76-105) under the control of the endogenous CENP-T promoter, mScarlet-CENP-T WT , ∆NBD-1 , or ∆NBD-2 cDNA was targeted into exon 1 by CRISPR/Cas9-mediated homologous recombination. Because the targeting constructs have puromycin resistance genes ( PuroR ) or neomycin resistance genes ( NeoR ), targeted cells were selected using these selection markers. The gRNA sequence and the position of primers for genotyping are shown. (D) Genotyping PCR for the GFP-mAID-CENP-T/OsTIR1 expression cassette in CENP-T WT , CENP-T ∆NBD−1 , or CENP-T ∆NBD−2 RPE1 cells. Genotyping in isolated single clones was performed using the primers shown in (B). WT RPE-1 cells were used as a control. (E) Genotyping PCR for targeted mScarlet-CENP-T in CENP-T WT , CENP-T ∆NBD−1 , or CENP-T ∆NBD−2 RPE1 cells. Genotyping in isolated single clones was performed using the primers shown in (C). WT RPE-1 cells were used as a control. (F) CENP-T protein expression in CENP-T WT , CENP-T ∆NBD−1 , or CENP-T ∆NBD−2 RPE-1 cells. The cells were treated with or without IAA for 1 d, and we examined GFP-mAID-CENP-T and mScarlet-CENP-T protein expression using an antibody against CENP-T or mScarlet (RFP). α-Tubulin was probed as a loading control. (G) Schematic representation of recruitment of KMN subcomplexes onto CENP-C or CENP-T in the human cells.

    Journal: Life Science Alliance

    Article Title: CENP-C-Mis12 complex establishes a regulatory loop through Aurora B for chromosome segregation

    doi: 10.26508/lsa.202402927

    Figure Lengend Snippet: (A) Strategy to generate CENP-T WT , CENP-T ∆NBD−1 , or CENP-T ∆NBD−2 RPE1 cells (see also ). In the cells, mini-auxin-inducible degron (mAID)–tagged human CENP-T was expressed together with OsTIR1 from the AAVS locus. Because mAID-fused CENP-T is degraded upon IAA (indole-3-acetic acid) treatment, mScarlet-tagged CENP-T is only expressed from the endogenous CENP-T locus in CENP-T WT , CENP-T ∆NBD−1 , or CENP-T ∆NBD−2 RPE1 cells. (B) Schematic representation of GFP-mAID-CENP-T and OsTIR1 cDNA targeting into the AAVS1 locus ( PPP1R12C gene). To express GFP- and mAID-fused human CENP-T and OsTIR1, the expression cassette was targeted into intron 1 by CRISPR/Cas9-mediated homologous recombination. Because the targeting construct has blasticidin resistance genes ( BsR ), targeted cells were selected using the BsR marker. The gRNA sequence and the position of primers for genotyping are shown. (C) Schematic representation of mScarlet-CENP-T cDNA targeting the endogenous CENP-T locus. To express mScarlet-tagged CENP-T WT or each of the Ndc80C-binding domain mutants (∆NBD-1: ∆6-31; ∆NBD-2: ∆76-105) under the control of the endogenous CENP-T promoter, mScarlet-CENP-T WT , ∆NBD-1 , or ∆NBD-2 cDNA was targeted into exon 1 by CRISPR/Cas9-mediated homologous recombination. Because the targeting constructs have puromycin resistance genes ( PuroR ) or neomycin resistance genes ( NeoR ), targeted cells were selected using these selection markers. The gRNA sequence and the position of primers for genotyping are shown. (D) Genotyping PCR for the GFP-mAID-CENP-T/OsTIR1 expression cassette in CENP-T WT , CENP-T ∆NBD−1 , or CENP-T ∆NBD−2 RPE1 cells. Genotyping in isolated single clones was performed using the primers shown in (B). WT RPE-1 cells were used as a control. (E) Genotyping PCR for targeted mScarlet-CENP-T in CENP-T WT , CENP-T ∆NBD−1 , or CENP-T ∆NBD−2 RPE1 cells. Genotyping in isolated single clones was performed using the primers shown in (C). WT RPE-1 cells were used as a control. (F) CENP-T protein expression in CENP-T WT , CENP-T ∆NBD−1 , or CENP-T ∆NBD−2 RPE-1 cells. The cells were treated with or without IAA for 1 d, and we examined GFP-mAID-CENP-T and mScarlet-CENP-T protein expression using an antibody against CENP-T or mScarlet (RFP). α-Tubulin was probed as a loading control. (G) Schematic representation of recruitment of KMN subcomplexes onto CENP-C or CENP-T in the human cells.

    Article Snippet: We amplified DNA fragments containing T7 promoter, gRNA target sequences (intron 1: CCAACACTATAGCTGACAAG; intron 4: AAACTGATAGAGTACAGTGG), and gRNA scaffold sequences by PCR using primers shown in Table S1 and pX330 (plasmid #42230; Addgene) ( ) as a template.

    Techniques: Expressing, CRISPR, Homologous Recombination, Construct, Marker, Sequencing, Binding Assay, Control, Selection, Isolation, Clone Assay

    (A) Strategy to generate CENP-T ∆M12BD RPE1 cells. In the cells, mini-auxin-inducible degron (mAID)–tagged human CENP-T was expressed together with OsTIR1 from the AAVS locus. Because mAID-fused CENP-T is degraded upon IAA (indole-3-acetic acid) treatment, mScarlet-tagged CENP-T is only expressed from the endogenous CENP-T locus in CENP-T ∆M12BD RPE1 cells. (B) Schematic representation of mScarlet-CENP-T cDNA targeting the endogenous CENP-T locus. To express mScarlet-tagged Mis12C-binding domain mutant CENP-T (∆M12BD: ∆107-230) or wild-type CENP-T under the control of the endogenous CENP-T promoter, mScarlet-CENP-T cDNAs were targeted into exon 1 by CRISPR/Cas9-mediated homologous recombination. Because the targeting constructs have puromycin resistance genes ( PuroR ) or neomycin resistance genes ( NeoR ), targeted cells were selected using these selection markers. The gRNA sequence and the position of primers for genotyping are shown. (C) Genotyping PCR for targeted mScarlet-CENP-T in CENP-T ∆M12BD RPE1 cells. Genotyping in isolated single clones was performed using the primers shown in (B). WT RPE-1 cells were used as a control. (D) CENP-T protein expression in CENP-T WT or CENP-T ∆M12BD RPE-1 cells. The cells were treated with or without IAA for 2 d, and we examined GFP-mAID-CENP-T and mScarlet-CENP-T protein expression using an antibody against CENP-T or mScarlet (RFP). α-Tubulin was probed as a loading control. (E) Schematic representation of human CENP-T. Human CENP-T WT has two Ndc80C-binding regions and a Mis12-binding domain (M12BD: amino acids 107–230). The M12BD region was deleted in CENP-T ∆M12BD . (F) DSN1 localization in CENP-T WT or CENP-T ∆M12BD RPE-1 cells. DSN1 was stained with an antibody against DSN1 (green). DSN1 localization at mitotic kinetochores was examined and quantified. mScarlet-CENP-T is a kinetochore marker (CENP-T, red). DNA was stained with DAPI (blue). Scale bar, 5 μm. Mean and SD, two-tailed t test, CENP-T WT RPE-1 cells: n = 10 cells; CENP-T ∆M12BD RPE-1 cells: n = 10 cells. (G) KNL1 localization in CENP-T WT or CENP-T ∆M12BD RPE-1 cells. KNL1 was stained with an antibody against KNL1 (green). mScarlet-CENP-T is a kinetochore marker (CENP-T, red). DNA was stained with DAPI (blue). KNL1 localization at mitotic kinetochores was examined and quantified. Scale bar, 5 μm. Mean and SD, two-tailed t test, CENP-T WT RPE-1 cells: n = 10 cells; CENP-T ∆M12BD RPE-1 cells: n = 10 cells. (H) Hec1 localization in CENP-T WT or CENP-T ∆M12BD RPE-1 cells. Hec1 was stained with an antibody against Hec1 (green). Hec1 localization at mitotic kinetochores was examined and quantified. Scale bar, 5 μm. Mean and SD, two-tailed t test, CENP-T WT RPE-1 cells: n = 10 cells; CENP-T ∆M12BD RPE-1 cells: n = 10 cells. (I) Bub1 localization in CENP-T WT or CENP-T ∆M12BD RPE-1 cells. Bub1 was stained with an antibody against Bub1 (green). mScarlet-CENP-T is a kinetochore marker (CENP-T, red). DNA was stained with DAPI (blue). Scale bar, 5 μm. Bub1 signal intensities at kinetochores were quantified (mean and SD, two-tailed t test, CENP-T WT RPE-1 cells: n = 363 kinetochores from 5 cells; CENP-T ∆M12BD RPE-1 cells: n = 346 kinetochores from 5 cells). (J) H2AT120ph localization in CENP-T WT or CENP-T ∆M12BD cells. H2AT120ph was stained with an antibody against H2AT120ph (green). mScarlet-CENP-T is a kinetochore marker (CENP-T, red). DNA was stained with DAPI (blue). Scale bar, 5 μm. H2AT120ph signal intensities at kinetochore-proximal centromeres were quantified (mean and SD, two-tailed t test, CENP-T WT RPE-1 cells: n = 297 kinetochores from 5 cells; CENP-T ∆M12BD RPE-1 cells: n = 366 kinetochores from 5 cells). (K) Aurora B localization in CENP-T WT or CENP-T ∆M12BD RPE-1 cells. Aurora B was stained with an antibody against Aurora B (green). mScarlet-CENP-T is a kinetochore marker (CENP-T, red). DNA was stained with DAPI (blue). Scale bar, 10 μm. The insets show an enlarged single chromosome (scale bar, 1 μm). Aurora B signal intensities at inner centromeres were quantified (mean and SD, two-tailed t test, CENP-T WT RPE-1 cells: n = 186 centromeres from 5 cells; CENP-T ∆M12BD RPE-1 cells: n = 207 centromeres from 5 cells).

    Journal: Life Science Alliance

    Article Title: CENP-C-Mis12 complex establishes a regulatory loop through Aurora B for chromosome segregation

    doi: 10.26508/lsa.202402927

    Figure Lengend Snippet: (A) Strategy to generate CENP-T ∆M12BD RPE1 cells. In the cells, mini-auxin-inducible degron (mAID)–tagged human CENP-T was expressed together with OsTIR1 from the AAVS locus. Because mAID-fused CENP-T is degraded upon IAA (indole-3-acetic acid) treatment, mScarlet-tagged CENP-T is only expressed from the endogenous CENP-T locus in CENP-T ∆M12BD RPE1 cells. (B) Schematic representation of mScarlet-CENP-T cDNA targeting the endogenous CENP-T locus. To express mScarlet-tagged Mis12C-binding domain mutant CENP-T (∆M12BD: ∆107-230) or wild-type CENP-T under the control of the endogenous CENP-T promoter, mScarlet-CENP-T cDNAs were targeted into exon 1 by CRISPR/Cas9-mediated homologous recombination. Because the targeting constructs have puromycin resistance genes ( PuroR ) or neomycin resistance genes ( NeoR ), targeted cells were selected using these selection markers. The gRNA sequence and the position of primers for genotyping are shown. (C) Genotyping PCR for targeted mScarlet-CENP-T in CENP-T ∆M12BD RPE1 cells. Genotyping in isolated single clones was performed using the primers shown in (B). WT RPE-1 cells were used as a control. (D) CENP-T protein expression in CENP-T WT or CENP-T ∆M12BD RPE-1 cells. The cells were treated with or without IAA for 2 d, and we examined GFP-mAID-CENP-T and mScarlet-CENP-T protein expression using an antibody against CENP-T or mScarlet (RFP). α-Tubulin was probed as a loading control. (E) Schematic representation of human CENP-T. Human CENP-T WT has two Ndc80C-binding regions and a Mis12-binding domain (M12BD: amino acids 107–230). The M12BD region was deleted in CENP-T ∆M12BD . (F) DSN1 localization in CENP-T WT or CENP-T ∆M12BD RPE-1 cells. DSN1 was stained with an antibody against DSN1 (green). DSN1 localization at mitotic kinetochores was examined and quantified. mScarlet-CENP-T is a kinetochore marker (CENP-T, red). DNA was stained with DAPI (blue). Scale bar, 5 μm. Mean and SD, two-tailed t test, CENP-T WT RPE-1 cells: n = 10 cells; CENP-T ∆M12BD RPE-1 cells: n = 10 cells. (G) KNL1 localization in CENP-T WT or CENP-T ∆M12BD RPE-1 cells. KNL1 was stained with an antibody against KNL1 (green). mScarlet-CENP-T is a kinetochore marker (CENP-T, red). DNA was stained with DAPI (blue). KNL1 localization at mitotic kinetochores was examined and quantified. Scale bar, 5 μm. Mean and SD, two-tailed t test, CENP-T WT RPE-1 cells: n = 10 cells; CENP-T ∆M12BD RPE-1 cells: n = 10 cells. (H) Hec1 localization in CENP-T WT or CENP-T ∆M12BD RPE-1 cells. Hec1 was stained with an antibody against Hec1 (green). Hec1 localization at mitotic kinetochores was examined and quantified. Scale bar, 5 μm. Mean and SD, two-tailed t test, CENP-T WT RPE-1 cells: n = 10 cells; CENP-T ∆M12BD RPE-1 cells: n = 10 cells. (I) Bub1 localization in CENP-T WT or CENP-T ∆M12BD RPE-1 cells. Bub1 was stained with an antibody against Bub1 (green). mScarlet-CENP-T is a kinetochore marker (CENP-T, red). DNA was stained with DAPI (blue). Scale bar, 5 μm. Bub1 signal intensities at kinetochores were quantified (mean and SD, two-tailed t test, CENP-T WT RPE-1 cells: n = 363 kinetochores from 5 cells; CENP-T ∆M12BD RPE-1 cells: n = 346 kinetochores from 5 cells). (J) H2AT120ph localization in CENP-T WT or CENP-T ∆M12BD cells. H2AT120ph was stained with an antibody against H2AT120ph (green). mScarlet-CENP-T is a kinetochore marker (CENP-T, red). DNA was stained with DAPI (blue). Scale bar, 5 μm. H2AT120ph signal intensities at kinetochore-proximal centromeres were quantified (mean and SD, two-tailed t test, CENP-T WT RPE-1 cells: n = 297 kinetochores from 5 cells; CENP-T ∆M12BD RPE-1 cells: n = 366 kinetochores from 5 cells). (K) Aurora B localization in CENP-T WT or CENP-T ∆M12BD RPE-1 cells. Aurora B was stained with an antibody against Aurora B (green). mScarlet-CENP-T is a kinetochore marker (CENP-T, red). DNA was stained with DAPI (blue). Scale bar, 10 μm. The insets show an enlarged single chromosome (scale bar, 1 μm). Aurora B signal intensities at inner centromeres were quantified (mean and SD, two-tailed t test, CENP-T WT RPE-1 cells: n = 186 centromeres from 5 cells; CENP-T ∆M12BD RPE-1 cells: n = 207 centromeres from 5 cells).

    Article Snippet: We amplified DNA fragments containing T7 promoter, gRNA target sequences (intron 1: CCAACACTATAGCTGACAAG; intron 4: AAACTGATAGAGTACAGTGG), and gRNA scaffold sequences by PCR using primers shown in Table S1 and pX330 (plasmid #42230; Addgene) ( ) as a template.

    Techniques: Binding Assay, Mutagenesis, Control, CRISPR, Homologous Recombination, Construct, Selection, Sequencing, Isolation, Clone Assay, Expressing, Staining, Marker, Two Tailed Test

    (A) Strategy to generate RPE-1 cell lines expressing DSN1 WT or DSN1 ∆BM with CENP-C WT or CENP-C ∆M12BD (CC WT /DSN1 WT , CC WT /DSN1 ∆BM , CC ∆M12BD /DSN1 WT , or CC ∆M12BD /DSN1 ∆BM RPE-1 cells). mScarlet-CENP-A was also expressed in all cell lines. The DSN1 basic motif (amino acids 91–113) was deleted in DSN1 ∆BM . (B) Schematic representation of mScarlet-DSN1 cDNA targeting the endogenous DSN1 locus. To express mScarlet-tagged DSN1 wild-type (WT) or a basic motif deletion mutant (∆BM: ∆91-113) under the control of the endogenous DSN1 promoter, mScarlet-DSN1 WT or ∆BM cDNAs were targeted into the DSN1 locus by CRISPR/Cas9-mediated homologous recombination. Because the targeting constructs have blasticidin S resistance genes ( BsR ), targeted cells were selected using the selection marker. The gRNA sequence and the position of primers for genotyping are shown. (C) Genotyping PCR and immunoblotting for CC WT /DSN1 WT , CC WT /DSN1 ∆BM , CC ∆M12BD /DSN1 WT , or CC ∆M12BD /DSN1 ∆BM RPE-1 cells. Genotyping in isolated single clones was performed using the primers shown in (B). In immunoblots, DSN1 was detected by an antibody against DSN1 or mScarlet (RFP), and α-tubulin was probed as a loading control. (D) DSN1 localization in CC WT /DSN1 WT , CC WT /DSN1 ∆BM , CC ∆M12BD /DSN1 WT , and CC ∆M12BD /DSN1 ∆BM RPE-1 cells. DSN1, a subunit of the Mis12C (green), was stained with an antibody against DSN1 (green). The mScarlet-CENP-A and mScarlet-DSN1 were used as a kinetochore marker (CENP-A/DSN1, red). DNA was stained with DAPI (blue). Scale bar, 5 μm. DSN1 signal intensities at mitotic kinetochores were quantified. A representative result from two independent experiments is shown (mean and SD, one-way ANOVA with Tukey’s multiple comparison test, CC WT /DSN1 WT RPE-1 cells: n = 10 cells; CC WT /DSN1 ∆BM RPE-1 cells: n = 10 cells; CC ∆M12BD /DSN1 WT RPE-1 cells: n = 10 cells; CC ∆M12BD /DSN1 ∆BM RPE-1 cells: n = 10 cells). (E) KNL1 localization in CC WT /DSN1 WT , CC WT /DSN1 ∆BM , CC ∆M12BD /DSN1 WT , and CC ∆M12BD /DSN1 ∆BM RPE-1 cells. KNL1 was stained with an antibody against KNL1 (green). The mScarlet-CENP-A and mScarlet-DSN1 were used as a kinetochore marker (CENP-A/DSN1, red). DNA was stained with DAPI (blue). Scale bar, 5 μm. DSN1 signal intensities at mitotic kinetochores were quantified. A representative result from two independent experiments is shown (mean and SD, one-way ANOVA with Tukey’s multiple comparison test, CC WT /DSN1 WT RPE-1 cells: n = 10 cells; CC WT /DSN1 ∆BM RPE-1 cells: n = 10 cells; CC ∆M12BD /DSN1 WT RPE-1 cells: n = 10 cells; CC ∆M12BD /DSN1 ∆BM RPE-1 cells: n = 10 cells). (F) Bub1 localization in CC WT /DSN1 WT , CC WT /DSN1 ∆BM , CC ∆M12BD /DSN1 WT , and CC ∆M12BD /DSN1 ∆BM RPE-1 cells. Bub1 was stained with an antibody against Bub1 (green). The mScarlet-CENP-A and mScarlet-DSN1 were used as a kinetochore marker (CENP-A/DSN1, red). DNA was stained with DAPI (blue). Scale bar, 5 μm. Bub1 signal intensities at mitotic kinetochores were quantified. A representative result from two independent experiments is shown (mean and SD, one-way ANOVA with Tukey’s multiple comparison test, CC WT /DSN1 WT RPE-1 cells: n = 354 kinetochores from 5 cells; CC WT /DSN1 ∆BM RPE-1 cells: n = 327 kinetochores from 5 cells; CC ∆M12BD /DSN1 WT RPE-1 cells: n = 375 kinetochores from 5 cells; CC ∆M12BD /DSN1 ∆BM RPE-1 cells: n = 386 kinetochores from 5 cells). (G) Aurora B localization in CC WT /DSN1 WT , CC WT /DSN1 ∆BM , CC ∆M12BD /DSN1 WT , and CC ∆M12BD /DSN1 ∆BM RPE-1 cells. Aurora B was stained with an antibody against Aurora B (green). The mScarlet-CENP-A and mScarlet-DSN1 were used as a kinetochore marker (CENP-A/DSN1, red). DNA was stained with DAPI (blue). Scale bar, 10 μm. The insets show an enlarged single chromosome (scale bar, 2 μm). Aurora B signal intensities at inner centromeres were quantified. A representative result from two independent experiments is shown (mean and SD, one-way ANOVA with Tukey’s multiple comparison test, CC WT /DSN1 WT RPE-1 cells: n = 228 kinetochores from 5 cells; CC WT /DSN1 ∆BM RPE-1 cells: n = 221 kinetochores from 5 cells; CC ∆M12BD /DSN1 WT RPE-1 cells: n = 215 kinetochores from 5 cells; CC ∆M12BD /DSN1 ∆BM RPE-1 cells: n = 212 kinetochores from 5 cells). (H) Aurora B localization in CC WT /DSN1 WT , CC WT /DSN1 ∆BM , CC ∆M12BD /DSN1 WT , and CC ∆M12BD /DSN1 ∆BM RPE-1 cells treated with 5-ITu for 30 min. Aurora B was stained with an antibody against Aurora B (green). The mScarlet-CENP-A and mScarlet-DSN1 were used as a kinetochore marker (CENP-A/DSN1, red). DNA was stained with DAPI (blue). Scale bar, 10 μm. The insets show enlarged chromosomes (scale bar, 2 μm). Aurora B signal intensities at the kinetochore-proximal pool were quantified. A representative result from two independent experiments is shown (mean and SD, one-way ANOVA with Tukey’s multiple comparison test, CC WT /DSN1 WT RPE-1 cells: n = 387 kinetochores from 5 cells; CC WT /DSN1 ∆BM RPE-1 cells: n = 389 kinetochores from 5 cells; CC ∆M12BD /DSN1 WT RPE-1 cells: n = 381 kinetochores from 5 cells; CC ∆M12BD /DSN1 ∆BM RPE-1 cells: n = 395 kinetochores from 5 cells).

    Journal: Life Science Alliance

    Article Title: CENP-C-Mis12 complex establishes a regulatory loop through Aurora B for chromosome segregation

    doi: 10.26508/lsa.202402927

    Figure Lengend Snippet: (A) Strategy to generate RPE-1 cell lines expressing DSN1 WT or DSN1 ∆BM with CENP-C WT or CENP-C ∆M12BD (CC WT /DSN1 WT , CC WT /DSN1 ∆BM , CC ∆M12BD /DSN1 WT , or CC ∆M12BD /DSN1 ∆BM RPE-1 cells). mScarlet-CENP-A was also expressed in all cell lines. The DSN1 basic motif (amino acids 91–113) was deleted in DSN1 ∆BM . (B) Schematic representation of mScarlet-DSN1 cDNA targeting the endogenous DSN1 locus. To express mScarlet-tagged DSN1 wild-type (WT) or a basic motif deletion mutant (∆BM: ∆91-113) under the control of the endogenous DSN1 promoter, mScarlet-DSN1 WT or ∆BM cDNAs were targeted into the DSN1 locus by CRISPR/Cas9-mediated homologous recombination. Because the targeting constructs have blasticidin S resistance genes ( BsR ), targeted cells were selected using the selection marker. The gRNA sequence and the position of primers for genotyping are shown. (C) Genotyping PCR and immunoblotting for CC WT /DSN1 WT , CC WT /DSN1 ∆BM , CC ∆M12BD /DSN1 WT , or CC ∆M12BD /DSN1 ∆BM RPE-1 cells. Genotyping in isolated single clones was performed using the primers shown in (B). In immunoblots, DSN1 was detected by an antibody against DSN1 or mScarlet (RFP), and α-tubulin was probed as a loading control. (D) DSN1 localization in CC WT /DSN1 WT , CC WT /DSN1 ∆BM , CC ∆M12BD /DSN1 WT , and CC ∆M12BD /DSN1 ∆BM RPE-1 cells. DSN1, a subunit of the Mis12C (green), was stained with an antibody against DSN1 (green). The mScarlet-CENP-A and mScarlet-DSN1 were used as a kinetochore marker (CENP-A/DSN1, red). DNA was stained with DAPI (blue). Scale bar, 5 μm. DSN1 signal intensities at mitotic kinetochores were quantified. A representative result from two independent experiments is shown (mean and SD, one-way ANOVA with Tukey’s multiple comparison test, CC WT /DSN1 WT RPE-1 cells: n = 10 cells; CC WT /DSN1 ∆BM RPE-1 cells: n = 10 cells; CC ∆M12BD /DSN1 WT RPE-1 cells: n = 10 cells; CC ∆M12BD /DSN1 ∆BM RPE-1 cells: n = 10 cells). (E) KNL1 localization in CC WT /DSN1 WT , CC WT /DSN1 ∆BM , CC ∆M12BD /DSN1 WT , and CC ∆M12BD /DSN1 ∆BM RPE-1 cells. KNL1 was stained with an antibody against KNL1 (green). The mScarlet-CENP-A and mScarlet-DSN1 were used as a kinetochore marker (CENP-A/DSN1, red). DNA was stained with DAPI (blue). Scale bar, 5 μm. DSN1 signal intensities at mitotic kinetochores were quantified. A representative result from two independent experiments is shown (mean and SD, one-way ANOVA with Tukey’s multiple comparison test, CC WT /DSN1 WT RPE-1 cells: n = 10 cells; CC WT /DSN1 ∆BM RPE-1 cells: n = 10 cells; CC ∆M12BD /DSN1 WT RPE-1 cells: n = 10 cells; CC ∆M12BD /DSN1 ∆BM RPE-1 cells: n = 10 cells). (F) Bub1 localization in CC WT /DSN1 WT , CC WT /DSN1 ∆BM , CC ∆M12BD /DSN1 WT , and CC ∆M12BD /DSN1 ∆BM RPE-1 cells. Bub1 was stained with an antibody against Bub1 (green). The mScarlet-CENP-A and mScarlet-DSN1 were used as a kinetochore marker (CENP-A/DSN1, red). DNA was stained with DAPI (blue). Scale bar, 5 μm. Bub1 signal intensities at mitotic kinetochores were quantified. A representative result from two independent experiments is shown (mean and SD, one-way ANOVA with Tukey’s multiple comparison test, CC WT /DSN1 WT RPE-1 cells: n = 354 kinetochores from 5 cells; CC WT /DSN1 ∆BM RPE-1 cells: n = 327 kinetochores from 5 cells; CC ∆M12BD /DSN1 WT RPE-1 cells: n = 375 kinetochores from 5 cells; CC ∆M12BD /DSN1 ∆BM RPE-1 cells: n = 386 kinetochores from 5 cells). (G) Aurora B localization in CC WT /DSN1 WT , CC WT /DSN1 ∆BM , CC ∆M12BD /DSN1 WT , and CC ∆M12BD /DSN1 ∆BM RPE-1 cells. Aurora B was stained with an antibody against Aurora B (green). The mScarlet-CENP-A and mScarlet-DSN1 were used as a kinetochore marker (CENP-A/DSN1, red). DNA was stained with DAPI (blue). Scale bar, 10 μm. The insets show an enlarged single chromosome (scale bar, 2 μm). Aurora B signal intensities at inner centromeres were quantified. A representative result from two independent experiments is shown (mean and SD, one-way ANOVA with Tukey’s multiple comparison test, CC WT /DSN1 WT RPE-1 cells: n = 228 kinetochores from 5 cells; CC WT /DSN1 ∆BM RPE-1 cells: n = 221 kinetochores from 5 cells; CC ∆M12BD /DSN1 WT RPE-1 cells: n = 215 kinetochores from 5 cells; CC ∆M12BD /DSN1 ∆BM RPE-1 cells: n = 212 kinetochores from 5 cells). (H) Aurora B localization in CC WT /DSN1 WT , CC WT /DSN1 ∆BM , CC ∆M12BD /DSN1 WT , and CC ∆M12BD /DSN1 ∆BM RPE-1 cells treated with 5-ITu for 30 min. Aurora B was stained with an antibody against Aurora B (green). The mScarlet-CENP-A and mScarlet-DSN1 were used as a kinetochore marker (CENP-A/DSN1, red). DNA was stained with DAPI (blue). Scale bar, 10 μm. The insets show enlarged chromosomes (scale bar, 2 μm). Aurora B signal intensities at the kinetochore-proximal pool were quantified. A representative result from two independent experiments is shown (mean and SD, one-way ANOVA with Tukey’s multiple comparison test, CC WT /DSN1 WT RPE-1 cells: n = 387 kinetochores from 5 cells; CC WT /DSN1 ∆BM RPE-1 cells: n = 389 kinetochores from 5 cells; CC ∆M12BD /DSN1 WT RPE-1 cells: n = 381 kinetochores from 5 cells; CC ∆M12BD /DSN1 ∆BM RPE-1 cells: n = 395 kinetochores from 5 cells).

    Article Snippet: We amplified DNA fragments containing T7 promoter, gRNA target sequences (intron 1: CCAACACTATAGCTGACAAG; intron 4: AAACTGATAGAGTACAGTGG), and gRNA scaffold sequences by PCR using primers shown in Table S1 and pX330 (plasmid #42230; Addgene) ( ) as a template.

    Techniques: Expressing, Mutagenesis, Control, CRISPR, Homologous Recombination, Construct, Selection, Marker, Sequencing, Western Blot, Isolation, Clone Assay, Staining, Comparison

    (A) Strategy to generate DSN1 WT or DSN1 ∆BM HeLa cell lines (see also ). (B) Schematic representation of mScarlet-DSN1 cDNA targeting the endogenous DSN1 locus. To express mScarlet-tagged DSN1 WT or a basic motif deletion mutant (∆BM: ∆91-113) under the control of the endogenous DSN1 promoter, mScarlet-DSN1 WT or ∆BM cDNAs were targeted into the DSN1 locus by CRISPR/Cas9-mediated homologous recombination. Because the targeting constructs have puromycin resistance genes ( PuroR ) or neomycin resistance genes ( NeoR ), targeted cells were selected using these selection markers. The gRNA sequence and the position of primers for genotyping are shown. (C) Genotyping PCR and immunoblotting for mScarlet-DSN1 in mScarlet-DSN1 –introduced HeLa cells. Genotyping in isolated single clones was performed using the primers shown in (B). In immunoblots, DSN1 was detected by an antibody against DSN1 or mScarlet (RFP), and α-tubulin was probed as a loading control. (D) Hec1 and KNL1 localization in DSN1 WT or DSN1 ∆BM HeLa cells. Hec1 (green) and KNL1 (cyan) were stained with antibodies against Hec1 and KNL1, respectively. mScarlet-DSN1 is a kinetochore marker (DSN1, red). DNA was stained with DAPI (blue). Scale bar, 5 μm. Hec1 or KNL1 signal intensities at mitotic kinetochores were quantified. A representative result from two independent experiments is shown (mean and SD, two-tailed t test, DSN1 WT : n = 7; DSN1 ∆BM : n = 7).

    Journal: Life Science Alliance

    Article Title: CENP-C-Mis12 complex establishes a regulatory loop through Aurora B for chromosome segregation

    doi: 10.26508/lsa.202402927

    Figure Lengend Snippet: (A) Strategy to generate DSN1 WT or DSN1 ∆BM HeLa cell lines (see also ). (B) Schematic representation of mScarlet-DSN1 cDNA targeting the endogenous DSN1 locus. To express mScarlet-tagged DSN1 WT or a basic motif deletion mutant (∆BM: ∆91-113) under the control of the endogenous DSN1 promoter, mScarlet-DSN1 WT or ∆BM cDNAs were targeted into the DSN1 locus by CRISPR/Cas9-mediated homologous recombination. Because the targeting constructs have puromycin resistance genes ( PuroR ) or neomycin resistance genes ( NeoR ), targeted cells were selected using these selection markers. The gRNA sequence and the position of primers for genotyping are shown. (C) Genotyping PCR and immunoblotting for mScarlet-DSN1 in mScarlet-DSN1 –introduced HeLa cells. Genotyping in isolated single clones was performed using the primers shown in (B). In immunoblots, DSN1 was detected by an antibody against DSN1 or mScarlet (RFP), and α-tubulin was probed as a loading control. (D) Hec1 and KNL1 localization in DSN1 WT or DSN1 ∆BM HeLa cells. Hec1 (green) and KNL1 (cyan) were stained with antibodies against Hec1 and KNL1, respectively. mScarlet-DSN1 is a kinetochore marker (DSN1, red). DNA was stained with DAPI (blue). Scale bar, 5 μm. Hec1 or KNL1 signal intensities at mitotic kinetochores were quantified. A representative result from two independent experiments is shown (mean and SD, two-tailed t test, DSN1 WT : n = 7; DSN1 ∆BM : n = 7).

    Article Snippet: We amplified DNA fragments containing T7 promoter, gRNA target sequences (intron 1: CCAACACTATAGCTGACAAG; intron 4: AAACTGATAGAGTACAGTGG), and gRNA scaffold sequences by PCR using primers shown in Table S1 and pX330 (plasmid #42230; Addgene) ( ) as a template.

    Techniques: Mutagenesis, Control, CRISPR, Homologous Recombination, Construct, Selection, Sequencing, Western Blot, Isolation, Clone Assay, Staining, Marker, Two Tailed Test